STK11 and non-small cell lung carcinoma: It is noteworthy that KEAP1 and STK11 did not affect survival in NSCLC patients who underwent surgical treatment (Supplementary Figures 1a, b), suggesting that their prognostic significance is specific to the context of immunotherapy.